Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2006 8
2007 2
2009 1
2010 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review.
Goffin J, Lacchetti C, Ellis PM, Ung YC, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Goffin J, et al. J Thorac Oncol. 2010 Feb;5(2):260-74. doi: 10.1097/JTO.0b013e3181c6f035. J Thorac Oncol. 2010. PMID: 20101151 Free article. Review.
INTRODUCTION: Non-small cell lung cancer (NSCLC) frequently presents at an incurable stage, and a majority of patients will be considered for palliative chemotherapy at some point in their disease. ...In patients at least 70 years of age or with Eastern Colla …
INTRODUCTION: Non-small cell lung cancer (NSCLC) frequently presents at an incurable stage, and a majority of patients will be …
18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review.
Ung YC, Maziak DE, Vanderveen JA, Smith CA, Gulenchyn K, Lacchetti C, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Ung YC, et al. J Natl Cancer Inst. 2007 Dec 5;99(23):1753-67. doi: 10.1093/jnci/djm232. Epub 2007 Nov 27. J Natl Cancer Inst. 2007. PMID: 18042932 Review.
Lung cancer is the leading cause of cancer-related death in industrialized countries. ...Diagnostic tests guide lung cancer management decisions, and clinicians increasingly use diagnostic imaging in an effort to improve the management of patien …
Lung cancer is the leading cause of cancer-related death in industrialized countries. ...Diagnostic tests guide lung …
Management of unresected stage III non-small cell lung cancer: a systematic review.
Okawara G, Mackay JA, Evans WK, Ung YC; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Okawara G, et al. J Thorac Oncol. 2006 May;1(4):377-93. J Thorac Oncol. 2006. PMID: 17409887 Free article. Review.
PURPOSE: To conduct a systematic review to determine the most effective therapy for patients with unresected stage III non-small cell lung cancer. METHODS: Relevant randomized trials and meta-analyses were identified through a systematic search of the literature. .. …
PURPOSE: To conduct a systematic review to determine the most effective therapy for patients with unresected stage III non-small cell lun …
The management of thymoma: a systematic review and practice guideline.
Falkson CB, Bezjak A, Darling G, Gregg R, Malthaner R, Maziak DE, Yu E, Smith CA, McNair S, Ung YC, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Falkson CB, et al. J Thorac Oncol. 2009 Jul;4(7):911-9. doi: 10.1097/jto.0b013e3181a4b8e0. J Thorac Oncol. 2009. PMID: 19557895 Free article. Review.
Stage IVB--treatment on an individual case basis (no generic recommendations). Recurrent disease--consider surgery, radiation, and/or chemoradiation. Chemoradiation should be considered in all medically inoperable and technically inoperable patients. CONCLUSION: Consensus …
Stage IVB--treatment on an individual case basis (no generic recommendations). Recurrent disease--consider surgery, radiation, and/or …
Postoperative chemotherapy in nonsmall cell lung cancer: a systematic review.
Alam N, Darling G, Shepherd FA, Mackay JA, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Alam N, et al. Ann Thorac Surg. 2006 May;81(5):1926-36. doi: 10.1016/j.athoracsur.2005.04.045. Ann Thorac Surg. 2006. PMID: 16631715 Review.
A systematic review of the evidence for postoperative chemotherapy in completely resected nonsmall cell lung cancer was conducted. Seven meta-analyses and 25 randomized trials met the pre-defined eligibility criteria for the review. The evidence indicates that posto …
A systematic review of the evidence for postoperative chemotherapy in completely resected nonsmall cell lung cancer was conduc …
Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline.
Cheng S, Evans WK, Stys-Norman D, Shepherd FA; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Cheng S, et al. J Thorac Oncol. 2007 Apr;2(4):348-54. doi: 10.1097/01.JTO.0000263720.15062.51. J Thorac Oncol. 2007. PMID: 17409809 Free article. Review.
PURPOSE: This clinical practice guideline, based on a systematic review, evaluates chemotherapy options for patients with relapsed small cell lung cancer (SCLC). METHODS: Relevant randomized trials and meta-analyses were identified through a systematic search of the …
PURPOSE: This clinical practice guideline, based on a systematic review, evaluates chemotherapy options for patients with relapsed small cel …
Use of the epidermal growth factor receptor inhibitors gefitinib and erlotinib in the treatment of non-small cell lung cancer: a systematic review.
Feld R, Sridhar SS, Shepherd FA, Mackay JA, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Feld R, et al. J Thorac Oncol. 2006 May;1(4):367-76. J Thorac Oncol. 2006. PMID: 17409886 Free article. Review.
INTRODUCTION: Inhibition of the epidermal growth factor receptor is a promising therapy in the treatment of non-small cell lung cancer (NSCLC). In this systematic review, we evaluated the role of the epidermal growth factor receptor inhibitors gefitinib and erlotini …
INTRODUCTION: Inhibition of the epidermal growth factor receptor is a promising therapy in the treatment of non-small cell lung ca …
The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline.
Ellis P, Davies AM, Evans WK, Haynes AE, Lloyd NS; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Ellis P, et al. J Thorac Oncol. 2006 Jul;1(6):591-601. J Thorac Oncol. 2006. PMID: 17409924 Free article. Review.
External feedback was obtained from Ontario clinicians, and the guideline was approved by the provincial Lung Cancer Disease Site Group. RESULTS: One hundred nineteen studies were eligible, including eight randomized trials and 111 phase II tria …
External feedback was obtained from Ontario clinicians, and the guideline was approved by the provincial Lung Cancer Diseas …
Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline.
Okawara G, Ung YC, Markman BR, Mackay JA, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Okawara G, et al. Lung Cancer. 2004 Apr;44(1):1-11. doi: 10.1016/j.lungcan.2003.09.020. Lung Cancer. 2004. PMID: 15013578 Review.
The Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care conducted a systematic review of literature published between 1985 and July 2003 and developed an evidence-based clinical practice guideline on pos …
The Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care conduct …
15 results